Invivogen
Menu

InvivoGen's product citations

Citations

InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
Puromycin A therapeutically targetable positive feedback loop between lnc-HLX-2-7, HLX,... 2024 Cell Rep. Katsushima K. et al. DOI: 10.1016/j.celrep.2024.113938
Blasticidin A therapeutically targetable positive feedback loop between lnc-HLX-2-7, HLX,... 2024 Cell Rep. Katsushima K. et al. DOI: 10.1016/j.celrep.2024.113938
MycoStrip™ - Mycoplasma Detection Kit MARCH2, a novel oncogene-regulated SNAIL E3 ligase, suppresses triple negativ... 2024 Cancer Res Commun. Ito K. et al. DOI: 10.1158/2767-9764.CRC-23-0090
Puromycin Neutralizing immunity against coronaviruses in Tanzanian health care workers. 2024 Sci Rep. Barabona G. et al. DOI: 10.1038/s41598-024-55989-4
Nigericin Protocol to measure apoptosis-associated speck-like protein containing a CARD... 2024 STAR Protoc. Sánchez K.E. et al. DOI: 10.1016/j.xpro.2024.102916
STING inhibitor DNA corona on nanoparticles leads to an enhanced immunostimulatory effect wit... 2024 PNAS Anees F. et al. DOI: 10.1073/pnas.2319634121
ODN 2088 DNA corona on nanoparticles leads to an enhanced immunostimulatory effect wit... 2024 PNAS Anees F. et al. DOI: 10.1073/pnas.2319634121
RU.521 DNA corona on nanoparticles leads to an enhanced immunostimulatory effect wit... 2024 PNAS Anees F. et al. DOI: 10.1073/pnas.2319634121
Primocin® Changes in chromatin accessibility and transcriptional landscape induced by H... 2024 Biomed Pharmacother. Gagliano T. et al. DOI: 10.1016/j.biopha.2024.116374
Primocin® Single-cell guided prenatal derivation of primary fetal epithelial organoids ... 2024 Nat Med. Gerli M.F.M. et al. DOI: 10.1038/s41591-024-02807-z
Normocin™ - Antimicrobial Reagent Overcoming doxorubicin resistance in triple-negative breast cancer using the ... 2024 Breast Cancer Res. Smoots S.G. et al. DOI: 10.1186/s13058-024-01799-5
R848 (Resiquimod) Protocol for localized macrophage stimulation with small-molecule TLR agonist... 2024 STAR Protoc. Mulder E.J. et al. DOI: 10.1016/j.xpro.2024.102873
MycoStrip™ - Mycoplasma Detection Kit The host-targeted antiviral drug Zapnometinib exhibits a high barrier to the ... 2024 Antiviral Res. Schreiber A. et al. DOI: 10.1016/j.antiviral.2024.105840
eSEAP Rational design of an artificial tethered enzyme for non-templated post-trans... 2024 Sci Rep. Le Boulch M. et al. DOI: 10.1038/s41598-024-55947-0
QUANTI-Blue™ Rational design of an artificial tethered enzyme for non-templated post-trans... 2024 Sci Rep. Le Boulch M. et al. DOI: 10.1038/s41598-024-55947-0
OVA protein Targeted deletion of CD244 on monocytes promotes differentiation into anti-tu... 2024 Mol Cancer Kim J. et al. DOI: 10.1186/s12943-024-01936-w
OVA peptides Targeted deletion of CD244 on monocytes promotes differentiation into anti-tu... 2024 Mol Cancer Kim J. et al. DOI: 10.1186/s12943-024-01936-w
LPS-EB (LPS from E. coli O111:B4) Hyperglycaemia amplifies TLR-mediated inflammatory response of M(IL4) macroph... 2024 J Leukoc Biol. Badillo-Garcia L.E. et al. DOI: 10.1093/jleuko/qiae050
Pam3CSK4 Hyperglycaemia amplifies TLR-mediated inflammatory response of M(IL4) macroph... 2024 J Leukoc Biol. Badillo-Garcia L.E. et al. DOI: 10.1093/jleuko/qiae050
LPS-EB VacciGrade™ Elevated CD169 expressing monocyte/macrophage promotes systemic inflammation ... 2024 Clin Exp Med. Xu L. et al. DOI: 10.1007/s10238-024-01305-3

Pages

Customer Service
& Technical Support
Contact us
Shopping cart is empty